Spontaneous Chelation-Driven Reduction of the Neptunyl Cation in Aqueous Solution

Octadentate hydroxypyridinone (HOPO) and catecholamide (CAM) siderophore analogues are known to be efficacious chelators of the actinide cations, and these ligands are also capable of facilitating both activation and reduction of actinyl species. Utilizing X-ray absorption near edge structure (XANES) and extended X-ray absorption fine structure (EXAFS) spectroscopies, as well as cyclic voltammetry measurements, herein, we elucidate chelation-based mechanisms for driving reactivity and initiating redox processes in a family of neptunyl–HOPO and CAM complexes. Based on the selected chelator, the ability to control the oxidation state of neptunium and the speed of reduction and concurrent oxo group activation was demonstrated. Most notably, reduction kinetics for the Np^VO₂^+//Np^IV redox couple upon chelation by the ligands 3,4,3-LI(1,2-HOPO) and 3,4,3-LI(CAM)₂(1,2-HOPO)₂ was observed to be faster than ever reported, and in fact quicker than we could measure using either X-ray absorption spectroscopy or electrochemical techniques.     

Stability constants of the aqueous mono-fluoride complexes of Pu(III) and Am(III) and their correlation with other metal ions

The stability constants of the aqueous mono-fluoride complexes of Pu(III) and Am(III) have been measured using the distribution method. A correlation of the available stability constants of fluoride complexes of trivalent actinides, up to Cf, with fundamental properties like charge and radii of the metal ion has been discussed. Good correlation within the group and as a part of other metal ions was obtained only for transplutonium elements. The reported stability constant values measured by potentiometry and the value obtained by distribution for Pu³⁺ appear to be much higher than expected from this correlation. However, a better correlation was obtained with transplutonium elements when effective charge instead of formal charge was considered for Pu³⁺ in the BSE function.     

Advancing understanding of actinide(iii) (Ac,Am, Cm) aqueous complexation chemistry

The positive impact of having access to well-defined starting materials for applied actinide technologies – and for technologies based on other elements – cannot be overstated. Of numerous relevant 5f-element starting materials, those in complexing aqueous media find widespread use. Consider acetic acid/acetate buffered solutions as an example. These solutions provide entry into diverse technologies, from small-scale production of actinide metal to preparing radiolabeled chelates for medical applications. However, like so many aqueous solutions that contain actinides and complexing agents, 5f-element speciation in acetic acid/acetate cocktails is poorly defined. Herein, we address this problem and characterize Ac³⁺ and Cm³⁺ speciation as a function of increasing acetic acid/acetate concentrations (0.1 to 15 M, pH = 5.5). Results obtained via X-ray absorption and optical spectroscopy show the aquo ion dominated in dilute acetic acid/acetate solutions (0.1 M). Increasing acetic acid/acetate concentrations to 15 M increased complexation and revealed divergent reactivity between early and late actinides. A neutral Ac(H₂O)₆₍₁₎(O₂CMe)₃₍₁₎ compound was the major species in solution for the large Ac³⁺. In contrast, smaller Cm³⁺ preferred forming an anion. There were approximately four bound O₂CMe¹⁻ ligands and one to two inner sphere H₂O ligands. The conclusion that increasing acetic acid/acetate concentrations increased acetate complexation was corroborated by characterizing (NH₄)₂M(O₂CMe)₅ (M = Eu³⁺, Am³⁺ and Cm³⁺) using single crystal X-ray diffraction and optical spectroscopy (absorption, emission, excitation, and excited state lifetime measurements).

Actinide complexation from aqueous acetic acid/acetate buffered solutions is described. The number of water ligands was directly correlated with the acetate concentration and characterized by X-ray absorption and optical spectroscopy.     

Single column ion exchange separation of the transplutonium elements from uranium targets bombarded with heavy ions and catcher foils

A simple pressurized ion exchange apparatus has been devised for rapid ion exchange separation of transplutonium elements synthesized by heavy ion bombardment. Cation exchange with mixed media of mineral acids and organic solvents at elevated temperature was used to separate the transplutonium elements from uranium targets and/or catcher foils (aluminium and copper) dissolved in aqua regia. The transplutonium elements were strongly adsorbed on the cation exchange column and separated in a group from rare earths by elution with hydrochloric acid or mutually separated with 2-hydroxy-2-methylpropionate solution. It has been successfully applied to separate and identify²⁵⁰Fm and²⁴⁶Cf synthesized by the¹⁶O+²³⁸U reaction.     

Curium isotopes in Chernobyl fallout

In nuclear reactors plutonium and transplutonium isotopes are produced by multiple neutron capture of uranium and plutonium and are important for the energy production and their composition reflects the core burnout. Under normal operation these elements are not released to the environment in significant amounts. There are accordingly very few areas or source terms where exotic transplutonium elements, such as curium isotopes, can be studied in the environment. The Chernobyl accident provided a complex spectrum of fission and activation products in fallout while the relative amounts, compared to the core inventory, of refractory elements such as transuranium and transplutonium elements were small. The major alpha-activity consisted of ²⁴²Cm (T _1/2 = 163 d) that would have decayed after a few years. In this study we have demonstrated the presence of so called supported ²⁴²Cm from the long-lived ²⁴²Am^m (T _1/2 = 141 a) in environmental samples, following fallout from the Chernobyl accident. It has also been possible to assess the core burn up by using the data obtained for the Cm isotopes. The curium isotopes ²⁴³Cm (T _1/2 = 29.1 a) and ²⁴⁴Cm (T _1/2 = 18.1 a) cannot be resolved by conventional alpha-spectrometry. The assessment of these isotopes in environmental samples contaminated from the Chernobyl accident has been made by studying the effective half-life of the mixture of the isotopes. The data are compared with those previously obtained by high-resolution alpha-spectrometry and spectral deconvolution.     

Preparation of samples for the α—Spectrometry of transplutonium elements

The electrolytic deposition of the hydroxides of rare earth and transplutonium elements on nickel holders from α-hydroxyisobutyrate solutions of 10⁻⁵ M to 5·10⁻¹ M concentrations has been investigated in the presence of ammonium chloride. It is shown that at total concentrations of ≥10⁻¹² M of rare earth and transplutonium elements, their electrodeposition proceeds with a 90% yield.     

Rare earth tungsten bronzes: a new method of synthesis. Perspectives for their application as inert matrices for transmutation of long-life actinide elements

A new method of synthesis of oxide tungsten bronzes containing lanthanide (Ln) Nd and Eu, based on thermal degradation of polyoxotungstate compounds, is proposed. The simplicity of the method allows to consider this class of compounds with chemical formula, Ln_xWO₃, as potential inert target for incineration or transmutation of minor actinides, Am and Cm, in neutron reactors. Nd and Eu were used as analogues of transplutonium elements. Powder X-ray diffraction patterns of compounds synthesized reveal a cubic perovskite structure. The lanthanide content in bronzes was determined by optical spectroscopy analysis. The experimental density of the pressed bronze samples was estimated at 6.58 g cm⁻³, i.e., 89% of the crystallographic value. The thermal stability of the bronzes synthesized was checked up to 900°C in an inert atmosphere. Leaching tests were performed for europium bronzes in nitric acid solutions using luminescence technique.     

Reversible metathesis of ammonia in an acyclic germylene–Ni0 complex

Carbenes, a class of low-valent group 14 ligand, have shifted the paradigm in our understanding of the effects of supporting ligands in transition-metal reactivity and catalysis. We now seek to move towards utilizing the heavier group 14 elements in effective ligand systems, which can potentially surpass carbon in their ability to operate via ‘non-innocent’ bond activation processes. Herein we describe our initial results towards the development of scalable acyclic chelating germylene ligands (viz.1a/b), and their utilization in the stabilization of Ni⁰ complexes (viz.4a/b), which can readily and reversibly undergo metathesis with ammonia with no net change of oxidation state at the Ge^II and Ni⁰ centres, through ammonia bonding at the germylene ligand as opposed to the Ni⁰ centre. The DFT-derived metathesis mechanism, which surprisingly demonstrates the need for three molecules of ammonia to achieve N–H bond activation, supports reversible ammonia binding at Ge^II, as well as the observed reversibility in the overall reaction.

Chelating single-centre ambiphile ligands based upon low-coordinate, acyclic germylenes have been developed, remaining highly Lewis acidic even when bound to Ni⁰, remarkably allowing for the reversible metathesis of the N–H bonds in ammonia at Ge^II.     

Intermetallics and alloys of transplutonium elements with metals of the platinum group

Americium and curium alloys with palladium and platinum containing up to 20% of actinide were prepared by the coupled reduction technique. The alloys obtained were investigated by X-ray, differential thermal analysis and metallography. Phase diagram sections for Pd–Am, Pd–Cm, Pt–Am and Pt–Cm systems have been constructed. Intermetallics Pt₅An (An=²⁴³Am,²⁴⁴Cm,²⁴⁹Bk,²⁴⁹Cf), Ir₂ ²⁴⁹Bk and Rh₃ ²³⁹Bk were obtained as thin layers on the surfaces of metallic substrates. X-ray investigation has shown that Pt₅An compounds have hexagonal structures of the Cu₅Ca-type, Ir₂Bk- cubic lattice of the Cu₂Mg-type and Rh₃Bk intermetallic has fcc lattice of the Cu₃Au-type. The influence of intensive -decay of transplutonium nuclides on the crystal structure of the intermetallics prepared has been investigated.     

“Bottled” spiro-doubly aromatic trinuclear [Pd2Ru]+ complexes

Following an ongoing interest in the study of transition metal complexes with exotic bonding networks, we report herein the synthesis of a family of heterobimetallic triangular clusters involving Ru and Pd atoms. These are the first examples of trinuclear complexes combining these nuclei. Structural and bonding analyses revealed both analogies and unexpected differences for these [Pd₂Ru]⁺ complexes compared to their parent [Pd₃]⁺ peers. Noticeably, participation of the Ru atom in the π-aromaticity of the coordinated benzene ring makes the synthesized compound the second reported example of ‘bottled’ double aromaticity. This can also be referred to as spiroaromaticity due to the participation of Ru in two aromatic systems at a time. Moreover, the [Pd₂Ru]⁺ kernel exhibits unprecedented orbital overlap of Ru d_z² AO and two Pd d_xy or d_x²−y² AOs. The present findings reveal the possibility of synthesizing stable clusters with delocalized metal–metal bonding from the combination of non-adjacent elements of the periodic table which has not been reported previously.

Synthesis of a triangular [Pd₂Ru]⁺ complex with delocalized metal–metal bonding between non-adjacent elements of the periodic table, double aromaticity and overlap of d-AOs with different angular momentum.     

Engineering lanmodulin's selectivity for actinides over lanthanides by controlling solvent coordination and second-sphere interactions

Developing chelators that combine high affinity and selectivity for lanthanides and/or actinides is paramount for numerous industries, including rare earths mining, nuclear waste management, and cancer medicine. In particular, achieving selectivity between actinides and lanthanides is notoriously difficult. The protein lanmodulin (LanM) is one of Nature''s most selective chelators for trivalent actinides and lanthanides. However, mechanistic understanding of LanM''s affinity and selectivity for f-elements remains limited. In order to decipher, and possibly improve, the features of LanM''s metal-binding sites that contribute to this actinide/lanthanide selectivity, we characterized five LanM variants, substituting the aspartate residue at the 9^th position of each metal-binding site with asparagine, histidine, alanine, methionine, and selenomethionine. Spectroscopic measurements with lanthanides (Nd³⁺ and Eu³⁺) and actinides (²⁴³Am³⁺ and ²⁴⁸Cm³⁺) reveal that, contrary to the behavior of small chelator complexes, metal-coordinated water molecules enhance LanM''s affinity for f-elements and pH-stability of its complexes. Furthermore, the results show that the native aspartate does not coordinate the metal directly but rather hydrogen bonds to coordinated solvent. By tuning this first-sphere/second-sphere interaction, the asparagine variant nearly doubles LanM''s selectivity for actinides versus lanthanides. This study not only clarifies the essential role of coordinated solvent for LanM''s physiological function and separation applications, but it also demonstrates that LanM''s preference for actinides over lanthanides can be further improved. More broadly, it demonstrates how biomolecular scaffolds possess an expanded repertoire of tunable interactions compared to most small-molecule ligands – providing an avenue for high-performance LanM-based actinide/lanthanide separation methods and bio-engineered chelators optimized for specific medical isotopes.

Nature’s most potent protein for f-elements, lanmodulin, relies on subtle first-sphere/second-sphere interactions to bind metal ions. Dissecting lanmodulin’s binding mechanism yielded variants with enhanced actinide/lanthanide selectivity.     

Phosphoryl- and phosphonium-bridged viologens as stable two- and three-electron acceptors for organic electrodes

Low molecular weight organic molecules that can accept multiple electrons at high reduction potentials are sought after as electrode materials for high-energy sustainable batteries. To date their synthesis has been difficult, and organic scaffolds for electron donors significantly outnumber electron acceptors. Herein, we report the synthesis and electronic properties of two highly electron-deficient phosphaviologen derivatives from a phosphorus-bridged 4,4''-bipyridine and characterize their electrochemical properties. Phosphaviologen sulfide (PVS) and P-methyl phosphaviologen (PVM) accept two and three electrons at high reduction potentials, respectively. PVM can reversibly accept three electrons between 3–3.6 V vs. Li/Li⁺ with an equivalent molecular weight of 102 g (mol⁻¹ e⁻) (262 mA h g⁻¹), making it a promising scaffold for sustainable organic electrode materials having high specific energy densities.

Two strongly electron-accepting viologens, including an intriguing tricationic species, are reported. The utility of the tricationic viologen for energy storage has been showcased via use as electrode in a proof-of-concept battery.     

The sporothriolides. A new biosynthetic family of fungal secondary metabolites

The biosynthetic gene cluster of the antifungal metabolite sporothriolide 1 was identified from three producing ascomycetes: Hypomontagnella monticulosa MUCL 54604, H. spongiphila CLL 205 and H. submonticulosa DAOMC 242471. A transformation protocol was established, and genes encoding a fatty acid synthase subunit and a citrate synthase were simultaneously knocked out which led to loss of sporothriolide and sporochartine production. In vitro reactions showed that the sporochartines are derived from non-enzymatic Diels–Alder cycloaddition of 1 and trienylfuranol A 7 during the fermentation and extraction process. Heterologous expression of the spo genes in Aspergillus oryzae then led to the production of intermediates and shunts and delineation of a new fungal biosynthetic pathway originating in fatty acid biosynthesis. Finally, a hydrolase was revealed by in vitro studies likely contributing towards self-resistance of the producer organism.

A new family of fungal biosynthetic pathways is elucidated based on the use of fatty acid and citrate-like intermediates.

Gamma-lactone and alkyl citrate compounds derived from oxaloacetate are widespread natural products in fungi and often possess potent biological activities. Examples include sporothriolide 1,^1,2 piliformic acid 2,³ tyromycin 3⁴ and the cyclic maleidrides including byssochlamic acid 4^5,6 among others (Fig. 1). In some cases, for example those of 4 and squalestatin S1 5,⁷ detailed molecular studies have revealed that a dedicated polyketide synthase (PKS) produces a carbon skeleton that is then condensed with oxaloacetate by a citrate synthase (CS) to give an early alkyl citrate intermediate that is further oxidatively processed. In other cases, such as 1 and the sporochartines 6, the biosynthetic pathways are not yet clear.Open in a separate windowFig. 1Structures of γ-lactone and alkyl citrate metabolites from fungi. Bold bonds show oxaloacetate-derived carbons where known.Sporochartines 6a–6d^8,9 from the fungus Hypoxylon monticulosum CLL 205 (now referred to as Hypomontagnella spongiphila)¹⁰ possesses potent cytotoxicity (IC₅₀: 7.2 to 21.5 μM) vs. human cancer cell lines and are proposed to be Diels Alder (DA) adducts of the furofurandione sporothriolide 1, itself a potent antifungal agent (EC₅₀: 11.6 ± 0.8 μM),¹¹ and trienylfuranol A 7,¹² originally obtained from an endophytic fungus Hypoxylon submonticulosum DAOMC 242471 (now referred to as Hypomontagnella submonticulosa).¹³ Since the biosynthesis of sporothriolide 1 and related compounds is unknown, and biological DA reactions in fungi are currently of high interest,¹⁴ we decided to examine the biosynthesis of the sporochartines 6 in the Hypomontagnella spp. strains MUCL 54604 and CLL 205 (ref. 10 and 13) in detail.     

Self-irradiation induced structural changes in the transplutonium pyrochlores An2Zr2O7 (An=Am, Cf)

We have pursued the fundamental chemistry of actinide pyrochlore oxides, An₂Zr₂O₇ (An=Am, Cm, Bk, and Cf), using X-ray diffraction as well as optical spectroscopy. One recent facet of our studies has been to observe the structural changes of these materials under self-irradiation as a function of time. It has been reported that both titanate and silicate materials transform from a crystalline to an amorphous state under irradiation. With the Zr-based actinide pyrochlores studied here, we have observed a phase change from a pyrochlore structure to a fluorite-type structure with the retention of crystallinity. We focus here on the impact of α-radiation (²⁴³Am and ²⁴⁹Cf), rather than that from neutrons (²⁴⁸Cm) or β-radiation (²⁴⁹Bk), on the An₂Zr₂O₇ pyrochlore structures. As a result of this phase change, the local coordination environments of both the actinide and zirconium atoms are altered. We consider a defect/ion deficiency driven mechanism and also address the occurrence of oxidation of the trivalent actinides during the self-irradiation process as being potential mechanisms responsible for the observed phase change.     

Electromigration method for destructive determination of spent nuclear fuel burnup

In this report we discuss the methods and results of VVER spent fuel burnup determination by¹⁴⁶Nd content and the correlation with accumulation of some transplutonium nuclides. For separation of trivalent rare earths and transplutonium elements the method of paper electrophoresis is used. For the quantitative determination of americum and curium isotopes a modification of α-spectrometric analysis is proposed with the chemical yield control of isolated elements using²⁴⁴Cm. The amount of¹⁴³Nd is determined by the isotopic dilution method combined with mass spectrometry with¹⁴²Nd as a tracer.     

Heparin reversal by an oligoethylene glycol functionalized guanidinocalixarene

Unfractionated heparin (UFH), a naturally occurring anionic polysaccharide, is widely used as an anticoagulant agent in clinical practice. When overdosed or used in sensitive patients, UFH may cause various risks and a UFH neutralizer needs to be administered immediately to reverse heparinization. However, the most common UFH neutralizer, protamine sulfate, often causes various adverse effects, some of which are life-threatening. Herein, we designed a highly biocompatible, oligoethylene glycol functionalized guanidinocalixarene (GC4AOEG) as an antidote against UFH. GC4AOEG and UFH exhibited a strong binding affinity, ensuring specific recognition and neutralization of UFH by GC4AOEG in vitro and in vivo. As a consequence, UFH-induced excessive bleeding was significantly alleviated by GC4AOEG in different mouse bleeding models. Additionally, no adverse effects were observed during these treatments in vivo. Taken together, GC4AOEG, as a strategically designed, biocompatible artificial receptor with strong recognition affinity towards UFH, may have significant clinical potential as an alternative UFH reversal agent.

An oligoethylene glycol functionalized guanidinocalix[4]arene was developed as a safe antidote against heparin, via specific recognition and neutralization of heparin in vitro and in vivo.

Heparin sodium, often referred to as unfractionated heparin (UFH, also known as heparin), is a well-known anionic glycosaminoglycan consisting of long, helical, unbranched chains of repeating sulfonated disaccharide units (Fig. 1).¹ It is currently a gold-standard life-saving drug to overcome blood coagulation by activating antithrombin-III to impede the coagulation process.^2,3 Systemic heparinization is the most common anticoagulation procedure in surgical practice (e.g. open-heart surgery) and extracorporeal therapies such as kidney dialysis. At the end of surgery, excess heparin often needs to be deactivated by using a heparin neutralizer; otherwise patients have risks of low blood pressure and a slow heart rate, and may develop internal bleeding.⁴ Therefore, the neutralization of heparin has been a topic of significant research interest in the biomedical field.Open in a separate windowFig. 1Scheme of heparin reversal by GC4AOEG in the circulatory system.Protamine sulfate, the only FDA-approved neutralizer of UFH, possesses a highly positive charge density due to its polymeric nature and rich arginine residues. Thus, electrostatic interactions are the major driving force in the formation of a UFH–protamine complex, leading to the neutralization and deactivation of UFH.^1,5 However, due to its non-specific interactions, protamine sulfate often causes various adverse effects such as bradycardia, hypotension and pulmonary hypertension, as well as allergic reactions including life-threatening anaphylactic reactions in some patients.⁵ When overdosed, protamine may further impair the intricate balance in the blood and cause coagulopathy.^5–7 Given these issues, there has been a medical need for alternative, safe UFH neutralizers that can specifically counteract UFH without causing serious adverse effects.⁸Discovering and developing new heparin neutralizers has been a popular area of research.^8,9 During the past two decades, a variety of different UFH neutralizers including small molecules,¹⁰ cationic polymers (e.g. polybrene),^11–14 peptides,^11,15 and nanoparticles^16,17 have been designed and evaluated in vitro and/or in vivo. For instance, surfen, as a small-molecule antagonist of UFH, may electrostatically bind with UFH; however only modest neutralizing effects against UFH were observed in rats,^10,18 likely attributed to the lack of strong, specific recognition. On the other hand, polycationic species, including polybrene¹⁹ and poly-dl-lysine,²⁰ exhibited stronger binding with UFH and significant potential as UFH neutralization agents. However, toxicity was still a key concern of these species due to their intrinsic electrostatic interactions with red blood cells (RBC).²¹ Meanwhile, some UFH antagonists have achieved preliminary success in preclinical studies and even moved to clinical evaluations. For instance, ciraparantag (PER977), as a synthetic antidote against several anticoagulants, is currently being evaluated in phase II clinical trials.²² UHRA (Universal Heparin Reversal Agent), a synthetic multivalent dendrimer polymer in the form of nanoparticles with positively charged surfaces, can reverse the activity of all clinically available heparins and it is currently undergoing preclinical studies and will likely move to clinical investigations.²³ However, the oligo- and poly-cationic nature of these species suggests their general tendency towards any negatively charged species, making them “universal” or function against several anticoagulants, implying their low specificity towards heparin.More recently, the sequestration and reversal of toxic agents by supramolecular host molecules have attracted increasing attention, and a typical example of clinical and commercial success is sugammadex, a carboxylated derivative of gamma-cyclodextrin that may specifically reverse the activity of non-depolarizing neuromuscular blocking agents.²⁴ Inspired by this clinical success, several macrocycles were designed and synthesized to selectively bind UFH. For instance, Liu et al. synthesized amphiphilic multi-charged cyclodextrins (AMCD), and AMCD-assembly was utilized for selective heparin binding.¹⁶ Nitz et al. derivatized a cyclodextrin with amide and guanidino groups as a polycationic receptor to recognize and detect UFH.²⁵ Kostiainen and co-workers studied cationic, quaternary ammonium functionalized pillar[5]arene because of its potential complexation with UFH.²⁶ Additionally, cationic calixarene derivatives were designed for UFH binding and guanidinocalixarenes exhibited stronger binding affinity with UFH than their quaternary amine-functionalized counterparts.^27,28 In spite of decent binding affinities and selective recognition of UFH, these macrocycles still possess various limitations such as non-specific toxicity induced mostly by cationic charges, which may disrupt cell membranes and induce blood coagulation.^29,30An ideal UFH neutralizer should full-fill the following three requirements: (1) binding strongly towards UFH in a specific manner; (2) excellent biocompatibility and safety profile, and (3) a clearly defined molecular structure to facilitate batch-to-batch consistency. Thus far, none of the clinical UFH antagonists or previously reported candidates has fulfilled these conditions. Herein we designed an artificial receptor, an oligoethylene glycol functionalized guanidinocalixarene, GC4AOEG, by leveraging the asymmetrical structure of calixarene to strategically add guanidinium groups on one side and oligoethylene glycol (OEG) groups on the other side (Fig. 1). We anticipated that the guanidinium-enriched upper rim would bind strongly with UFH via salt bridges (charge-assisted hydrogen bonds).^28,31 In addition, the biocompatible OEG-functionalized lower rim may help improve the water-solubility and biocompatibility of the host molecule.^32,33GC4AOEG was synthesized in 5 steps starting from the maternal calix[4]arene (Fig. 2). Briefly, p-tert-butylcalix[4]arene 1 was alkylated with tosylate 2³⁴ to obtain compound 3 with a well-defined cone conformation, and replacement of the tert-butyl with nitro groups via an ipso-nitration reaction afforded compound 4.³⁵ Subsequently, compound 4 was hydrogenated in the presence of SnCl₂·2H₂O, affording the tetramine derivative 5. Subsequently, compound 6 was obtained via a reaction between compound 5 and di-Boc-protected thiourea units. The removal of the protecting groups was achieved using SnCl₄ in ethyl acetate, to yield the target GC4AOEG (the characterization of intermediates (Fig. S1 and S2) and GC4AOEG (Fig. S3) are in the ESI^†).Open in a separate windowFig. 2Synthetic route of GC4AOEG and fluorescence titrations. (A(a)) NaH, dry DMF, and 75 °C; (b) HNO₃, AcOH, dry CH₂Cl₂, and r.t.; (c) SnCl₂·2H₂O, C₂H₅OH/AcOEt (1 : 1, v/v), and reflux; (d) 1,3-bis(tert-butoxycarbonyl)-2-methyl-2-thiopseudourea, Et₃N, AgNO₃, dry CH₂Cl₂, and r.t.; (e) SnCl₄, AcOEt, and r.t. (B) Direct fluorescence titration of 0.5 μM EY with different concentrations of GC4AOEG (up to 13.8 μM) in HEPES buffer (10 mM, pH = 7.4), and λ_ex = 517 nm. (Inset) The associated titration curve at λ_em = 537 nm and best fit according to a 1 : 1 binding stoichiometry. (C) Competitive fluorescence titration of GC4AOEG·EY (4.0/0.5 μM) with UFH (up to 8.4 μM in the concentration of monomer units of UFH), and λ_ex = 517 nm. (Inset) The associated titration curve at λ_em = 537 nm and best fit according to a n : 1 competitive binding model, where n = 0.88.The binding affinity between GC4AOEG and UFH was firstly investigated via a competitive titration approach. In this paper, we defined the repeated disaccharide unit as the UFH monomer unit, and the UFH concentration in this paper is the UFH monomer unit concentration. Eosin Y (EY) was selected as the reporter dye, owing to its strong complexation with GC4AOEG and the drastic fluorescence quenching after complexation. The equilibrium association constant (K_a), between GC4AOEG and EY, was determined by direct fluorescence titration and fitted as (2.37 ± 0.12) × 10⁵ M⁻¹ with 1 : 1 binding stoichiometry (Fig. 2B). The displacement of EY from GC4AOEG·EY by gradual addition of UFH resulted in the recovery of the intrinsic emission of EY. The best-fitting of the competitive titration model afforded ca. 1 : 1 binding stoichiometry between GC4AOEG and each monomer unit of UFH, as well as an ultrahigh binding affinity K_a of (1.25 ± 0.13) × 10⁷ M⁻¹ (Fig. 2C).For in vitro analysis of the effectiveness of GC4AOEG against UFH, the activated partial thromboplastin time (aPTT) assay was conducted. The result (Fig. S8^†) indicates that one equivalent of GC4AOEG (to UFH monomer) fully neutralized UFH, similar to protamine. Very importantly, it is obvious that protamine alone negatively influenced the aPTT time. In contrast, GC4AOEG alone did not affect the clotting time, suggesting that GC4AOEG can specifically bind with UFH directly with minimal side influences. The coagulation factor X levels in the plasma analyzed via the enzyme-linked immunosorbent assay (ELISA) further confirmed the safety and reversal effect of GC4AOEG towards UFH (Fig. S9^†).Next, the biocompatibility of GC4AOEG was investigated in vitro. As an alkyl derivative of guanidinocalixarene, GC4A-6C (Fig. S4 and S5^†), which has a similar number of carbons (hexyl groups) at the lower rim to that of GC4AOEG, was also synthesized and examined in this study for comparative purposes. As shown in Fig. 3A and B, GC4AOEG (up to 200 μM) showed remarkably low cytotoxicity in several cell lines via MTT assays, in dramatic contrast to the relatively high cytotoxicity of GC4A-6C (Fig. 3C and D). The cellular toxicity of GC4A-6C was consistent with previous literature.³⁶ In addition, alkyl derivatives of calixarene were generally more toxic than those without alkyl chains,³⁷ likely attributed to their amphiphilic properties that may facilitate cell membrane disruption.^38–40 The results suggested that the much-improved safety profile of GC4AOEG was attributed to oligoethylene glycol functionalization. Meanwhile, it is well known that cationic polymers or oligomers often show poor biocompatibility in the circulation system due to their non-selective binding to negatively charged RBC, resulting in RBC aggregation or hemolysis.⁴¹ Therefore, hemolysis and hemagglutination assays were conducted according to a method previously reported,^42,43 with experimental details described in the method. The percent hemolysis of GC4A-6C (25, 50, 100 and 200 μM, respectively) was over 90%, which would limit its application in the circulatory system (Fig. S6^†), as a hemolysis ratio below 5% is considered safe.⁴⁴ Conversely, GC4AOEG exhibited nearly negligible (less than 3%) hemolytic activity at concentrations of up to 200 μM, and no agglutination was visualized during incubation with RBC (Fig. 3F), implying that OEG functionalization at the lower rim reduced non-specific interactions with the RBC membrane, resulting in less disturbance of the membrane structure and function or cellular aggregations.Open in a separate windowFig. 3Biocompatibility study in cell lines and RBC. Cell viabilities of (A, C) 4T1 and (B, D) 293T, cells treated with different concentrations of GC4AOEG or GC4A-6C for 24 h. Each data point represents the mean ± S.E.M. from a set of experiments (n = 4). (E, G) Hemolysis test of GC4AOEG at different concentrations (NC = negative control; PC = positive control). Each data point represents the mean ± S.E.M. from a set of experiments (n = 3). (F) Agglutination test of RBC incubated with GC4AOEG at 2.0% hematocrit in normal saline.Inspired by the above findings, we further examined whether GC4AOEG may reverse bleeding in different mouse bleeding models under heparinization (with the experimental details described in the method, and the standard curve for the quantification of blood loss volume is showed in Fig. S7^†),⁴⁵ with both the total time of bleeding and total volume of lost blood evaluated for each model. As a proof of concept, 200 U kg⁻¹ UFH and 2.245 mg kg⁻¹ GC4AOEG (molar ratio of GC4AOEG and each monomer unit of UFH = 1 : 1) were respectively used, as representative doses in the study and the dose of UFH was based on a literature report.⁴⁶ In a mouse tail transection model as an external bleeding model, as shown in Fig. 4A–C, after tail transection, the bleeding time and blood loss volume for mice treated with normal saline were 58.9 ± 10.7 min and 72.2 ± 15.8 μL, respectively. As expected, treatment with UFH increased the bleeding time and blood volume to 121.5 ± 20.2 min and 264.0 ± 43.6 μL, respectively. In contrast, the bleeding time was dramatically reduced down to the blank control level, when the mice were treated with GC4AOEG at the same time of, or 30 s after, i.v. administration of UFH (53.8 ± 11.4 min and 89.0 ± 13.3 min, respectively). Accordingly, the blood loss volume of mice successively treated with UFH and GC4AOEG (1 : 1 ratio) reached the control level (72.6 ± 14.3 μL), indicating that the strong binding affinity between GC4AOEG and UFH ensured their recognition in vivo. Of note, there was no significant difference between the GC4AOEG treated group (without heparinization) and the saline treated group, suggesting a decent safety profile of the artificial receptor.Open in a separate windowFig. 4Reversal efficacy in in vivo mouse models. (A–C) Mouse tail transection model. (A) Scheme of the mouse tail transection model. (B) Total time of bleeding and (C) blood loss volume. (D–F & J) Mouse liver injury model. (D) Scheme of the mouse liver injury model. (E) Total time of bleeding and (F) blood loss weight. (J) Pictures exhibiting bleeding in liver injury before and after treatment. (G–I & K) Mouse femoral artery model. (G) Scheme of the mouse femoral artery model. (H) Total time of bleeding and (I) blood loss weight. (K) Pictures exhibiting bleeding in the femoral artery before and after treatment. All of those models were i.v. administration with normal saline (control), GC4AOEG (2.245 mg kg⁻¹), or UFH (200 U kg⁻¹) without and with GC4AOEG (2.245 mg kg⁻¹, 1 : 1 molar stoichiometry of GC4AOEG and the monomer unit of UFH), and UFH–GC4AOEG 1 : 1 successively (GC4AOEG at a dose of 2.245 mg kg⁻¹ 30 s after UFH administration) respectively were quantified. Data presented are the mean ± S.E.M. (n = 6). *p < 0.05, ****p < 0.001, and ns represents “no significant difference” between the experimental group and the control group.In addition to external bleeding, internal bleeding such as liver injury model (Fig. 4D) was established in mice, and GC4AOEG''s reversal of UFH was further evaluated in vivo. Mice were i.v. administered with normal saline (control), GC4AOEG (2.245 mg kg⁻¹), or UFH (200 U kg⁻¹) without and with GC4AOEG (2.245 mg kg⁻¹), and successive UFH–GC4AOEG 1 : 1 (30 s in between), respectively. In 2 minutes, the abdomen was surgically opened to expose the liver. A wound of 0.5 cm length and 2 mm depth, in the left lobe of the liver, was created. Considerable bleeding was immediately observed in the UFH treatment group (Fig. 4J), with the total bleeding time lasting for 450.5 ± 46.8 s, and the total blood loss of 571.0 ± 35.0 mg, in contrast to 143.7 ± 14.7 s total bleeding time and 238.0 ± 45.0 mg total blood loss observed in the saline treated group. Interestingly, the UFH–GC4AOEG treated group showed no significant difference from the normal saline treated group. To simulate the clinical use scenario, GC4AOEG was injected after UFH''s administration, and significantly reduced bleeding (from both time and volume perspectives) was observed, suggesting effective inhibition of the adverse effects of UFH, by GC4AOEG (Fig. 4E and F). GC4AOEG alone (without heparinization) did not exhibit any hematological toxicity in this model. To further evaluate the inhibitory effects of GC4AOEG against UFH in a preclinical model, a more serious internal bleeding model, femoral artery bleeding mouse model, was employed, and the treatment plan followed the previous two models described as above. Upon administration, the skin of the right leg and the overlying muscles were removed to expose the femoral artery and sciatic nerve. After an open injury at the middle segment of the femoral artery was created with a surgical scissor, blood gushed out immediately from the injured site (Fig. 4G and K). As shown in Fig. 4H and I, the longest average bleeding time (16.0 ± 1.9 min) and blood loss weight (103.8 ± 16.9 mg) were observed in the UFH treatment group of mice, in dramatic contrast to the bleeding time and blood loss of 3.9 ± 0.4 min and 24.7 ± 4.5 mg, respectively, in the normal saline treated group of mice. A bleeding time of 3.6 ± 0.4 min and blood loss of 20.8 ± 7.4 mg were recorded in the UFH–GC4AOEG treatment group. When UFH and GC4AOEG (at 1 molar equivalent) were successively injected, a bleeding time of 5.3 ± 0.7 min and blood loss of 27.7 ± 5.8 mg were noted, suggesting the significant reversal effects of GC4AOEG on UFH. Collectively, in all of the three bleeding models including internal and external bleeding models, i.v. administration of GC4AOEG significantly reversed UFH-induced excessive bleeding in external and internal injuries. More importantly, GC4AOEG alone exhibited negligible hematological activity, unlike other previously reported cationic small molecules, polymers, oligomers and macrocycles.Furthermore, in order to further verify the safety profile of GC4AOEG at the effective dose in vivo, acute toxicity evaluation was performed in a mouse model. After the i.v. injection of GC4AOEG in mice at a dose of 2.245 mg kg⁻¹ (i.v. injection of normal saline as the control group), the body weight, behaviors, and overall survival of the treated mice were monitored every day for 3 weeks. All the treated mice remained alive and showed normal behaviors, as well as normal body weight evolvement similar to that of the control group (Fig. 5A). On day 21 post administration, mice were euthanized for blood and organ samples were harvested (for details see the method). The organ indexes of representative major organs including the heart, liver, spleen, lungs, and kidneys isolated from the GC4AOEG treated mice were comparable to those of the mice administered with normal saline, with no significant differences observed (Fig. 5B). Hematological parameters such as the counts of whole blood cells (WBCs), red blood cells (RBCs), platelets (PLTs) and hemoglobin (HGB) (Fig. 5C), as well as the serum concentrations of liver and kidney function biomarkers including blood urea nitrogen (BUN), creatinine (crea), urea alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were all analyzed thoroughly (Fig. 5D and E). These results indicated that the hematological parameters, renal and hepatic functions of the mice treated with GC4AOEG were comparable with those of the mice in the normal saline treated group. Moreover, histopathological examinations of the major organs of the GC4AOEG treated mice showed normal microstructures comparable with those of the control group (Fig. 5F). Collectively, these results suggested that the i.v. administration of GC4AOEG at the therapeutic dose is safe.Open in a separate windowFig. 5Preliminary acute toxicity evaluations on GC4AOEG. (A) Weight changes of mice after i.v. administration with a single dose of GC4AOEG. (B) Major organ indexes of the mice on day 21 post-administration with GC4AOEG. (C) Hematological parameters of the blood samples collected from the mice on day 21 after i.v. administration of GC4AOEG. (D) Renal and (E) hepatic functional biomarkers in the blood samples collected from the mice on day 21 after i.v. administration of GC4AOEG. Data are presented as mean ± S.E.M.; n = 6 for each group. (F) H&E histopathological analysis of the major organs from mice sacrificed 21 days after being injected with saline and GC4AOEG (2.245 mg kg⁻¹). Scale bar = 100 μm.     

Preparation of actinide targets for the synthesis of the heaviest elements

The heaviest elements are synthesized in heavy-ion induced hot fusion reactions with various actinide targets. Because the actinide material is often available only in very limited amounts, a deposition method with high yields (~90 %) is needed. We report on the production of ²⁴⁴Pu, ²⁴³Am, ²⁴⁸Cm, ²⁴⁹Bk, and ²⁴⁹Cf targets on thin Ti backings by molecular plating. Different chemical purification steps using ion chromatographic techniques were applied for the purification of ²⁴⁹Cf and ²⁴⁴Pu. The deposition procedure applied for the production of ~0.4–0.8 mg/cm² thick targets is described. The deposition yield was determined either by α-particle or γ-ray spectroscopy. Furthermore, neutron activation analysis has been applied in the case of ²⁴⁴Pu, ²⁴³Am, and ²⁴⁸Cm. Information about the spatial distribution and homogeneity of the target layer was obtained by radiographic imaging.     

New chemistry for enhanced carbon capture: beyond ammonium carbamates

Carbon capture and sequestration is necessary to tackle one of the biggest problems facing society: global climate change resulting from anthropogenic carbon dioxide (CO₂) emissions. Despite this pressing need, we still rely on century-old technology—aqueous amine scrubbers—to selectively remove CO₂ from emission streams. Amine scrubbers are effective due to their exquisite chemoselectivity towards CO₂ to form ammonium carbamates and (bi)carbonates, but suffer from several unavoidable limitations. In this perspective, we highlight the need for CO₂ capture via new chemistry that goes beyond the traditional formation of ammonium carbamates. In particular, we demonstrate how ionic liquid and metal–organic framework sorbents can give rise to capture products that are not favourable for aqueous amines, including carbamic acids, carbamate–carbamic acid adducts, metal bicarbonates, alkyl carbonates, and carbonic acids. These new CO₂ binding modes may offer advantages including higher sorption capacities and lower regeneration energies, though additional research is needed to fully explore their utility for practical applications. Overall, we outline the unique challenges and opportunities involved in engineering new CO₂ capture chemistry into next-generation technologies.

New pathways for carbon capture and sequestration are needed to tackle the challenge of rising anthropogenic carbon dioxide emissions.